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Abstract: Hpn-like (Hpnl) is a unique histidine- and glutamine-rich protein found only in 
Helicobacter pylori and plays a role on nickel homeostasis. We constructed the fluorescent sensor 
proteins CYHpnl and CYHpnl_1-48 (C-terminal glutamine-rich region truncated) using enhanced 
cyan and yellow fluorescent proteins (eCFP and eYFP) as the donor-acceptor pair to monitor the 
interactions of Hpnl with metal ions and to elucidate the role of conserved Glu-rich sequence in 
Hpnl by fluorescence resonance energy transfer (FRET). CYHpnl and CYHpnl_1-48 exhibited 
largest responses towards Ni(II) and Zn(II) over other metals studied and the binding of Bi(III) to 
CYHpnl was observed in the presence of excess amount of Bi(III) ions (Kd= 115 ± 4.8 μM). 
Moreover, both CYHpnl and CYHpnl_1-48 showed positive FRET responses towards the binding to 
Ni(II) and Zn(II) in E. coli cells overexpressing CYHpnl and CYHpnl_1-48, whereas a decrease in 
FRET upon Bi(III)-binding in E. coli cells overexpressing the latter. Our study provides clear 
evidence on Hpnl binding to nickel in cells, and intracellular interaction of Hpnl with Bi(III) could 
disrupt the protein function, thus probably contributing to the efficacy of Bi(III) drugs against H. 
pylori.   
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1. Introduction 
Helicobacter pylori resides in acidic gastric environment and infects more than 50% of the world 
population, leading to peptic ulcer and even gastric cancer [1,2]. Two nickel-containing 
metalloenzymes, [NiFe] hydrogenase [3,4] and urease [5-7], are essential for the survival and 
colonization of H. pylori under extremely low pH condition [8]. Intracellular level of nickel is thus 
tightly regulated in uptake, trafficking, storage and release, accounting to its necessity and toxicity 
[7,9,10]. Histidine-rich Hpn and histidine- and glutamine-rich Hpn-like (Hpnl) proteins have been 
found to serve as nickel reservoirs in H. pylori, which supply the metal for the maturation of 
hydrogenase and urease (Table S4-S5) [6,11-14]. In scarce nickel condition, wild-type H. pylori 
colonizes more efficiently in mice than both hpn and hpnl gene deleted H pylori, pinpointing the 
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importance of Hpn and Hpnl in H. pylori colonization under its physiological condition [15]. 
Although the role of Hpnl has been proposed, its interaction with metal ions in actual cellular 
environment has not been clearly demonstrated.  
 Bismuth-based medications, such as colloidal bismuth subcitrate (DeNol
®
, Lizhudele
®
), 
bismuth subsalicylate (Pepto-Bismol
®
) and ranitidine bismuth citrate (Pylorid
®
), have been used for 
the treatment of microbe-causing gastrointestinal infections for decades, in particular to eradicate 
H. pylori infection when combined with antibiotics [16-20]. Proteins, especially enzymes, are 
believed to be the therapeutic targets although the molecular mechanism of bismuth drugs is not 
fully understood and the intracellular monitoring of drug actions is still lacking [5,15,17].   
 Fluorescence resonance energy transfer (FRET) has been widely used to examine the reaction 
kinetics through monitoring the conformational changes of biomolecules upon their interactions 
with corresponding substrates [21-23]. Fluorescent proteins frequently serve as FRET donor-
acceptor pairs given that they can be genetically-encoded to the proteins of interest, and the fusion 
proteins are expressed for fluorescence studies inside cells [24,25]. Moreover, genetically-encoded 
FRET sensors can also be used to elucidate the concentration of metal ions in cells, owing to their 
abilities of accurately targeting various subcellular organelles [24,26,27]. 
 In this work, we engineered a fluorescent sensor protein CYHpnl to examine the interaction of 
Hpnl towards various metal ions by FRET, utilizing eCFP and eYFP as the FRET donor-acceptor 
pair. To investigate the role of highly conserved C-terminal glutamine-rich sequence, a mutant of 
CYHpnl (CYHpnl_1-48) was constructed and similar study was carried out. We further explored the 
metal-binding properties of Hpnl by overexpressing CYHpnl or CYHpnl_1-48 in bacterial cells. The 
metal selectivity of Hpnl in vitro and in cells is compared and the effect of bismuth drug is 
discussed.   
2. Experimental  
2.1  Materials   
Primers were synthesized by Life Technologies. All chemicals were purchased from Sigma-Aldrich 
or USB, and were used without further purification. 
 
2.2 Construction of pET32a-eCFP-Hpnl-eYFP and C-terminal glutamine-deleted mutant  pET32a-
eCFP-Hpnl_NoCterQ-eYFP expression vectors 
The full-length ecfp and eyfp genes were PCR-amplified from plasmids pECFP-Nuc and pEYFP-
C1 (Clontech Laboratories) by primer pairs (CFP-For/CFP-Rev and YFP-For/YFP-Rev). The hpnl 
gene was amplified from H. pylori 11637 genomic DNA using primer Hpnl-For/Hpnl-Rev (Table 
S1). After digestion by corresponding restriction endonucleases (New England Biolabs), the PCR 
products ecfp and eyfp were successively inserted into pET32a vector to obtain the plasmid 
pET32a-eCFP-eYFP and hpnl gene was inserted between ecfp and eyfp genes to obtain the plasmid 
pET-eCFP-Hpnl-eYFP (named pET-CYHpnl hereafter). Linkers with a sequence of Gly-Ser-Gly-
Ser were inserted among the genes of ecfp, hpnl and eyfp to enhance the flexibility and solubility of 
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the sensors. 
 For the C-terminal glutamine-deleted mutant pET32a-eCFP-Hpnl_1-48-eYFP (named pET-
CYHpnl_1-48 hereafter), hpnl gene was amplified with primer pair (Hpnl-For/Hpnl-NoCQ-Rev) 
and the mutant hpnl gene was inserted into pET32a-eCFP-eYFP plasmid. Plasmid pET28a-eCFP-
eYFP (named pET-CYFP hereafter) was also constructed to produce a fluorescent sensor protein 
consisting of only the flexible linker (Gly-Ser-Gly-Ser) between the genes of eCFP-eYFP FRET 
donor-acceptor pair for control experiments. 
 
2.3  Expression and purification of CYHpnl and CYHpnl_1-48 
Plasmids pET-CYHpnl and pET-CYHpnl_1-48 were transformed into Escherichia coli BL21(DE3). 
The overnight culture was subcultured into fresh Luria-Bertani (LB) medium with 1:100 dilution 
supplemented with 100 g/ml ampicillin and was grown at 37 °C until OD600 reached 0.6. Protein 
expression was induced overnight at 25 °C in the presence of 0.2 mM isopropyl-D-1- 
thiogalactopyranoside (IPTG). Bacterial pellets were harvested by centrifugation and resuspended 
in buffer A (20 mM Tris-HCl, pH 7.6, 500 mM NaCl, and 1 mM tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP)) supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF). 
 Cells were lysed by sonication, then the lysates was centrifuged at 10,000 g at 4 °C for 30 
minutes and the supernatant was applied to HisTrap HP column (GE Healthcare). The column was 
washed with buffer A in the presence of increasing amount of imidazole (from 20 to 150 mM) and 
the protein was eluted with buffer A containing 200 mM imidazole. Fractions were collected and 
were analysed by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
(Fig. S1). The peak fraction was further purified by Resource Q column (GE Healthcare) with a 
linear gradient of NaCl from 0 to 500 mM and the peak fractions were pooled and dialyzed against 
Buffer B (10 mM 2-(N-morpholino)ethanesulfonic acid (MES), pH 6.8, 150 mM (NH4)2SO4) three 
times at 4 °C for six hours for subsequent use. Protein concentration was determined by BCA 
Protein Assay Kit (Novagen). ICP-MS analysis (Agilent 7500a spectrometer) was performed to 
ensure the protein remained as an apo-form prior to fluorescence analysis.  
2.4  In vitro FRET analysis 
 Full fluorescence emission spectra were obtained on a Hitachi F7000 Fluorescence 
Spectrophotometer using 1 cm x 1 cm quartz cuvette. CYHpnl (250 nM in Buffer B) was excited at 
433 nm with 1000 W xenon lamp source at the excitation and emission slit width of 5 nm. The 
photomultiplier voltage was set to be 650 V and emission spectra were scanned from 450 to 650 nm 
at a speed of 40 nm per second.  
 Fluorescence experiments were carried out on a Beckman Coulter DTX880 Multimode 
Detector, using the excitation filter 405/30 nm and emission filter 465/30 nm and 535/30 nm. 
Intensity ratio of the two emission signals (emission ratio= 535/30: 465/30) was used to quantify 
the FRET changes. Metal stock solutions were prepared from NiSO4, ZnSO4, CoSO4, MnSO4, 
MgSO4, CuSO4 and Bi(NO3)3 (in glycerol). Molar equivalents of various metal ions were added to 
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400 nM of CYHpnl or CYHpnl_1-48 or CYFP (as a control) in Buffer B. The changes in FRET 
emission ratio (emission at filters 535/30:465/30) were calculated by averaging the results of at 
least three replicates. 
 
2.5  Metal-binding capacities of CYHpnl 
 The dissociation constants (Kd) for Ni(II)- and Zn(II)-CYHpnl were determined by 
equilibrium dialysis. Apo-CYHpnl (20 μM) solution was filled into home-made dialysis tubes (3 
kDa cutoff) and was dialyzed against Buffer B supplemented with a series of concentrations of 
Ni(II) and Zn(II) ions overnight at 4°C. ICP-MS was employed to determine the metal 
concentrations in and outside the dialysis tubes while nonlinear fitting with Hill equation in 
GraphPad Prism 5 (Y = Bmax*X^h / (Kd^h + X^h), where Bmax is the maximum specific binding, h 
is the Hill coefficient and Kd is the dissociation constant) was used to calculate the dissociation 
constant (Kd) for Ni(II)- and Zn(II)-binding to CYHpnl after normalization with protein 
concentration. 
 To determine the Kd of Bi(III) to CYHpnl, nonlinear fitting with Hill equation in GraphPad 
Prism 5 (Y = Bmax*X^h / (Kd^h + X^h)) was employed to analyze the FRET results with titration of 
Bi to CYHpnl.  To determine the stoichiometries of metal binding to CYHpnl, CYHpnl (20 M) was 
incubated with six molar equivalents of Ni(II), Co(II), Cu(II) Zn(II) and Bi(III) and excess metal 
ions were removed by buffer exchange prior to ICP-MS analysis.  
 
2.6  FRET analysis in E. coli cells  
 Plasmid pET-CYHpnl or pET-CYHpnl_1-48 was transformed into BL21(DE3) E. coli cells. 
An overnight culture was inoculated into fresh LB medium in the presence of 100 μg/ml ampicillin. 
Cells were harvested by centrifugation at 4,000 rpm when OD600 reached 0.6 and were 
subsequently washed three times with freshly prepared MOPS minimal medium [28] containing 
100 μg/ml ampicillin. Cells were then grown at 37 °C in MOPS minimal medium for 30 minutes 
after washing for recovery. Protein expression was induced at 25 °C for at least 16 hours with the 
use of 0.2 mM IPTG. The OD600 of bacterial culture was measured and subsequently diluted to the 
OD600 of 0.4. Various concentrations of Ni(II), Zn(II) and Bi(III) ions (as colloidal bismuth 
subcitrate), ranged from 0 to 200 μM, were then added to the bacterial cell culture medium for four-
hour incubation at 25 °C prior to fluorescence measurement. Samples were subjected to Beckman 
Coulter DTX880 Multimode Detector for fluorescence measurement with the same setting as in in 
vitro FRET experiments. CYFP-overexpressed E. coli cells were also subjected to FRET analysis 
after four-hour incubation with Ni(II), Zn(II), Mg(II) and Bi(III) (0 - 200 μM) as a control. 
 
 
3. Results  
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3.1  Detection of metal binding by FRET and in vitro metal selectivity and affinity of CYHpnl 
  
                                       
Fig. 1 (A) Sequence alignment of three strains of H. pylori by MUSCLE (Jalview) 
[29]
, showing the 
highly-conserved histidine- (purple) and glutamine (green) residues in Hpnl. (B) Both full length 
and C-terminal-truncated Hpnl sequence were inserted between the FRET partners, eCFP and 
eYFP. Conformational changes were induced upon the interaction with metal ions. (C) 
Fluorescence spectra of CYHpnl in the absence and presence of Ni(II) ions (λex = 433 nm). 
 
The strategy for the design and fabrication of the fluorescent sensor proteins are illustrated in Fig. 
1B. We first investigated the occurrence of FRET between eCFP and eYFP due to the 
conformational change in the target Hpnl protein by fluorescence spectroscopy using purified 
CYHpnl. Addition of Ni(II) ions to CYHpnl led to a decrease in the eCFP fluorescence at 476 nm 
and an increase in the eYFP fluorescence (525 nm), with gradual changes in the eCFP and eYFP 
fluorescence emission upon the titration of increasing amount of Ni(II) ions, demonstrating the 
metal concentration-dependent change in FRET signals (Fig. 1C and Fig. S3). This is due to the 
conformational change of the Hpnl protein induced by Ni(II), resulting in a reduction in the 
distance between eCFP-eYFP FRET donor-acceptor pair. The quenching of eCFP fluorescence was 
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accomplished by the transfer of energy to the proximate eYFP molecule, leading to the decline in 
eCFP fluorescence and an upsurge of eYFP fluorescence in comparison with the apo-form of 
CYHpnl. Consequently, FRET efficiency can be quantified by the change in the FRET emission 
ratio (I525/I476). Metal binding to the target CYHpnl and CYHpnl_1-48 proteins can be detected by 
FRET, more specifically by the change in FRET ratio.  
 Previously, it has been demonstrated that Hpnl binds to Ni(II), Cu(II), Co(II) and Zn(II) with 
micromolar affinity (Table S5) [12]. To investigate the metal selectivity of the protein, CYHpnl 
(400 nM) was incubated with various metal ions (up to 2.4 μM), including Cu(II), Ni(II), Zn(II), 
Co(II), Mn(II), Mg(II) and Bi(III), and was subjected to fluorescence analysis as described in 
experimental section. Apparent increase in the FRET ratios were observed for Ni(II) and Zn(II) and 
the increase in the amount of these metals led to further enhancement of FRET ratio (Fig. 2). 
Maximum changes of approximately 35% and 20% in the FRET ratio were observed for Ni(II) and 
Zn(II) respectively. In contrast, less than 5% changes in the FRET ratio of CYHpnl were recorded 
for Cu(II), Co(II), Mn(II) and Bi(III) ions, which were similar to that of the control metal ions (i.e. 
Mg(II)). FRET analysis with the control CYFP showed little changes in FRET, indicating that the 
metal-induced FRET in CYHpnl was due to the interaction between metal and protein of interest 
Hpnl (Fig. S4). Circular dichroism (CD) was performed to investigate the changes in secondary 
structure of CYHpnl upon metal titration (Supporting information). It was found that apparent 
changes in secondary structure were induced upon interaction with Ni(II), followed by Zn(II), 
possibly elaborating the greatest change in FRET responses upon Ni(II) and Zn(II) titration (Fig. 
S5). Based on the FRET results, we concluded that Ni(II)- and Zn(II)-binding to CYHpnl can be 
selectively monitored by FRET but not other metal ions studied.  
                               
Fig. 2 Changes (%) in FRET ratio of CYHpnl (400 nM) upon the addition of different molar 
equivalents of metal ions. 
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Fig. 3 Binding of CYHpnl to Ni(II) and Zn(II) by equilibrium dialysis. The data were fitted with 
Hill equation. 
 
  To quantify the binding affinities of CYHpnl to Ni(II) and Zn(II), equilibrium dialysis was 
applied by supplementing Ni(II) and Zn(II) to the apo-protein and the results were analysed by non-
linear fitting with Hill equation (Fig. 3). CYHpnl was found to bind 2.5 ± 0.1 Ni(II) with the 
dissociation constants (Kd) of 4.6 ± 0.7  M with  cooperativity (h = 1.77 ± 0.37). CYHpnl bound 
3.3 ± 0.1 Zn(II) and the dissociation constants (Kd) was estimated to be 3.4 ± 0.4 M with 
cooperativity (h = 1.75 ± 0.36) (Fig. 3). The cooperativity (where h~ 2) detected might confirm that 
approximately two binding sites with certain extent of cooperativity are involved in Ni- and Zn-
binding to CYHpnl [30]. It was revealed that CYHpnl possesses similar binding affinities towards 
Ni(II) and Zn(II), comparable to those of native Hpnl [12]. Further analysis by ICP-MS confirmed 
that CYHpnl binds 2.2 ± 0.1 Ni(II) and 2.1 ± 0.2 Zn(II) (Table S2), almost identical to those of 
native Hpnl. It was, however, noted a discrepancy between the results in equilibrium dialysis and 
ICP-MS analysis in Zn-binding to CYHpnl. As it has been previously validated that Hpnl can only 
bind two Zn(II) [12], the extra Zn(II) ions associated with CYHpnl could thus be postulated to be 
possible weak non-specific interaction of Zn(II) with the fluorescent proteins. Nevertheless, the 
incorporation of eCFP and eYFP appeared to have little effect on the metal binding affinities of 
Hpnl to Ni(II) and Zn(II).  
 
3.2  Interaction between CYHpnl and Bi(III)  
 The N-terminus of Hpnl shares more than 50% sequence identity with that of Hpn in H. 
pylori (Fig. S9), which has been demonstrated to contribute to the Bi(III) tolerance by sequestering 
therapeutic Bi(III) drugs [14,31]. A previous FRET study demonstrated that the presence of 
bismuth in great surplus relative to the protein (at least an excess of 200-fold) was required to 
induce FRET responses in Bi(III)-binding Hpn in vitro [21]. To further examine whether CYHpnl 
binds Bi(III) ions, increasing amount of Bi(III) ions (as Bi(NO3)3 for up to 320 μM) was titrated 
into the purified CYHpnl (400 nM) and the changes in FRET signals were recorded.  
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Fig 4. Binding of Bi(III) to CYHpnl. An increase in FRET signal was not observed until the 
addition of 80 μM of Bi(III) ions to CYHpnl (400 nM). The data were fitted by the Hill equation. 
 
 No FRET signals were detected when low concentrations of Bi(III) ions were added to 
CYHpnl (400 nM). However, to our surprise, addition of 80 μM of Bi(III) led to observable FRET 
signals, which further increased by about 40% and reached a plateau at Bi(III) concentration of 120 
μM (Maximum FRET change, Bmax = 42.5 ± 2.2%). The binding curve was fitted by Hill equation 
to give rise to a dissociation constant (Kd) of 115.3 ± 4.8 μM with cooperativity (h = 12.2 ± 5.0), 
indicative of a very weak binding, much weaker than Hpn (Fig. 4) [21]. It has been pinpointed that 
the Hill coefficient could only reflect the minimal ligand binding sites in ligand-receptor interaction 
[30]. From the hill coefficient obtained from the fitting with Hill equation, approximately twelve 
binding sites with certain cooperativity were involved in Bi-binding to CYHpnl. To further monitor 
Bi(III)-binding to CYHpnl, column-based gel electrophoresis coupled with ICP-MS (GE-ICP-MS) 
was used according to our previous report (Supporting information) [32]. Upon incubation of 120 
M of Bi(III) (as Bi(NO3)3) for an overnight, CYHpnl was loaded onto column-based gel 
electrophoresis for the measurement of the 
209
Bi profile by ICP-MS whereas the molecular weight 
of the corresponding protein was calibrated by iodinated protein markers simultaneously. The 
evident bismuth signal observed at ~ 75 kDa confirming that CYHpnl binds Bi(III) at high Bi(III) 
concentration (Fig. S7D), indicative of the potentially specific binding of Bi(III) to Hpnl.  
 
3.3  Effect of glutamine residues on metal-CYHpnl interactions 
 Analysis on the sequences of three strains of H. pylori showed that the consecutive glutamine 
residues in Hpnl are highly conserved (Fig. 1A). The glutamine residues have been demonstrated to 
be able to stabilize metal ions in the binding site due to hydrogen bonding [33,34]. To understand 
the effect of the glutamine-rich sequence located at the C-terminus of Hpnl on its metal-binding 
properties, a mutant with the C-terminal glutamine-rich region truncated CYHpnl, i.e. CYHpnl_1-48, 
was constructed and similar experiments were performed with the purified protein.  
9 
 Similar to CYHpnl, incubation of increasing amount of Ni(II) and Zn(II) (up to 6 molar 
equivalents) with CYHpnl_1-48 resulted in maximum changes of about 30% and 20% in the FRET 
ratio, respectively (Fig. 5). Addition of different molar equivalents of Cu(II) produced a slight 
decrease in FRET ratio of about 10%, which might also suggest a possible interaction between 
CYHpnl_1-48 and Cu(II). Less than 5% changes in the FRET ratio were observed for Co(II), 
Mg(II), Mn(II) and Bi(III). Ni(II) and Zn(II) again induced the largest FRET responses (20% and 
30% respectively) in CYHpnl_1-48, indicating that the glutamine-rich C-terminus of Hpnl plays a 
little role in terms of metal-binding in vitro.  
                                     
Fig 5. Changes (%) in FRET ratio upon the addition of different molar equivalents of metal ions to 
purified CYHpnl_1-48 (400 nM). Note the evident changes of FRET induced by Ni(II) and Zn(II). 
 
3.4  Metal selectivity of CYHpnl and CYHpnl_1-48 in cells 
 To examine the metal selectivity of CYHpnl in cells, we performed similar experiments in 
live E. coli cells. CYHpnl-overexpressing cells were cultured in minimal medium supplemented 
with the target metal ions. No toxicity was observed within the working concentration of all added 
metal ions as reflected from the optical density at 600 nm. Upon incubation with Ni(II), Zn(II) and 
Bi(III) ions (as colloidal bismuth subcitrate) for four hours, FRET changes were detected from 50 
μM of Ni(II), Zn(II) and Bi(III) in CYHpnl-overexpressed E. coli and were saturated at about 100 
μM of all metal ions. Significant changes in FRET ratio were observed for Ni(II) and Zn(II) ions 
with around 20% increase in FRET ratio for both metal ions (P< 0.05, analyzed by unpaired t-test; 
two-tailed) (Fig. 6A). Approximately 10% change in FRET ratio was observed for Bi(III). Similar 
to in vitro studies, CYHpnl exhibited a higher selectivity towards Ni(II) and Zn(II) intracellularly. 
Analysis of FRET in CYFP-overexpressed cells showed that there was no evident FRET signals 
(about 5%), indicating that the FRET responses were resulted from the metal binding to Hpnl, but 
not due to non-specific interaction with the sensor protein itself (Fig. S8).  
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Fig. 6 Changes (%) in FRET ratio after the incubation with different metal ions in (A) CYHpnl and 
(B) CYHpnl_1-48 overexpressed E. coli. Data were analyzed by unpaired t-test; two-tailed with P < 
0.05 as indicated by the asterisks on the figure.  
 
 We showed that the deletion of C-terminal glutamine-rich sequence did not alter the metal-
binding properties of CYHpnl significantly (Fig. 5). We evaluated the metal selectivity of 
CYHpnl_1-48 in E. coli cells under identical conditions (Fig. 6B). Similar to CYHpnl protein, the 
largest increase in FRET ratio was observed upon the addition of Ni(II) to the cell culture medium 
(about 40%), indicating that the deletion of C-terminal glutamine-rich residues does not alter Ni(II) 
coordination to Hpnl protein. Intriguingly, addition of Zn(II) or Bi(III) ions resulted in decline in 
the FRET ratio, in particular about 20% negative FRET change for Bi(III), in contrast to the results 
obtained for the CYHpnl, suggesting that the C-terminal glutamine residues may play a role in 
metal binding inside cells.  
 To confirm that the FRET responses observed in vivo were due to the coordination of metal 
ions to CYHpnl (and CYHpnl_1-48), but not resulted from the disturbance of cellular metal 
homeostasis, the culture medium after protein overexpression was treated with EDTA (Supporting 
information). It has been reported previously that metal chelators like EDTA may increase the outer 
membrane permeability of gram-negative bacteria, facilitating some impermeable molecules to 
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cross the cell membrane [35]. Metal homeostasis would then be disturbed by EDTA treatment, after 
which its effects on FRET could be revealed. Less that 5% changes in FRET ratio were noticed 
after EDTA treatment (Fig. S6), demonstrating the negligible effect on FRET by the trace metal 
ions in culture medium.  
 To further validate the coordination of Bi(III) to CYHpnl_1-48 in cells, GE-ICP-MS was 
employed similarly [32] (Supporting information). To eliminate the background of Bi(III)-binding 
proteins in cells, E. coli cells with CYFP-overexpression was constructed and incubated with Bi(III) 
similarly prior to analysis of metals in cell lysates by GE-ICP-MS as a control. Two major 
209
Bi 
peaks were observed in the GE-ICP-MS profile of CYFP-overexpressed E. coli with molecular 
weights of about 29 and 50 kDa (Fig. S7A), indicative of potential Bi(III)-binding proteins in E. 
coli cells. However, there was no 
209
Bi peaks at molecular weight ~ 75 kDa. In contrast, a distinct 
peak at about 75 kDa was observed in GE-ICP-MS profile of cell lysate of CYHpnl_1-48-
overexpressed cells in addition to two 
209
Bi peaks corresponding to molecular weights of about 29 
and 50 kDa (Fig. S7B).  
  
4. Discussion 
 Many lower organisms including H. pylori require Ni(II) for specific functions. However, 
excessive Ni(II) ions are toxic to organisms. Given that H. pylori colonizes stomach where it is 
highly acidic, the proper functions of two Ni(II)-containing enzymes, urease and [Ni,Fe] 
hydrogenase, are crucial for the survival and colonization of the bacterium. The bacterium 
synthesizes two small and unique proteins, histidine-rich Hpn and histidine- and glutamine-rich 
Hpnl, for nickel storage and detoxification, similar to the functions of other histidine-rich proteins 
[11,13,15]. Histidine-rich proteins or histidine-rich motifs have also been shown to play a key role 
in metal homeostasis in a broad spectrum of bacterial species in a habitat-related manner [36]. 
Previous in vitro experiments have demonstrated that both Hpn and Hpnl bind to Ni(II) strongly 
and reversibly [11,13]. In addition, Hpn was shown to bind Bi(III) both in vitro and in vivo and 
might serve as one of the Bi(III) drug targets [14,21,31]. 
 In the present study, we constructed FRET sensors, CYHpnl and CYHpnl_1-48, based on a 
previous report [21]. Gradual changes in FRET were shown upon the addition of increasing amount 
of metal ions in in vitro and in intracellular studies, providing a solid elaboration of the FRET 
analyses. We found that protein CYHpnl binds two Ni(II) and two Zn(II) ions in vitro by ICP-MS 
(Table S2) with the dissociation constants at micromolar level as determined by equilibrium 
dialysis, despite the presence of weak non-specific interaction between Zn(II) and fluorescent 
proteins revealed in equilibrium dialysis (Fig. 3). The binding affinities of Ni(II) and Zn(II) to 
CYHpnl were similar to those of the native Hpnl protein (Table S5) [12]. No oligomeric state of 
CYHpnl and CYHpnl_1-48 was observed upon incubation with Ni(II), Zn(II) and Bi(III), 
confirming that the FRET changes were merely owing to the conformational changes of the 
proteins (Fig. S2). Importantly, evident changes of fluorescence (FRET ratio) in E. coli cells 
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overexpressing CYHpnl and CYHpnl_1-48 were observed in the presence of Ni(II) and Zn(II). In 
contrast, trivial changes for Co(II), Cu(II) and Mn(II) were observed (data not shown), indicative of 
intracellular binding of CYHpnl to Ni(II) and Zn(II). These results are in agreement with the 
proposed functions of Hpnl in H. pylori [11,12,15]. It has also been shown that Ni(II) induced the 
largest change in secondary structure in native Hpnl protein [12], which is also demonstrated in the 
CD spectra of CYHpnl (Fig. S5), i.e., the greatest conformational changes of CYHpnl were induced 
by Ni(II). The higher selectivity of CYHpnl towards Ni(II) ions observed in this FRET study may 
be related to the conformation of the intrinsic metal-binding sites of Hpnl that are structurally 
favourable towards specific metal ions.  
 Different from Hpn, Hpnl has unique glutamine-rich motifs, whose role remains unclear (Fig. 
S9). We, therefore, engineered a C-terminal glutamine truncated mutant (CYHpnl_1-48) to 
investigate the role of these highly conserved glutamine residues in Hpnl. Deletion of the C-
terminal glutamine residues did not lead to significant differences in FRET signals for all the metal 
ions studied in vitro, indicating that these glutamine residues might not be involved in direct 
binding to metal ions. Surprisingly, the changes of FRET ratio in vivo for CYHpnl_1-48 upon 
incubation with Ni(II) were doubled comparing with that of CYHpnl under similar conditions. 
Moreover, the interaction of CYHpnl_1-48 and Bi(III) ions in cells was disclosed with the FRET 
signals being significantly different from those without any added metal ions (Fig. 6). Glutamine-
rich motifs in proteins have been found to be involved in the reversible interaction between 
proteins, and their roles in facilitating protein oligomerization have also been suggested [34,37-39]. 
The glutamine-rich sequences in Hpnl might indirectly enhance the protein folding, introducing 
certain degree of rigidity in the structure of native Hpnl. Larger change in conformation might 
therefore be observed in the glutamine-rich sequence truncated mutant CYHpnl_1-48. Further 
biological investigation on the role of the glutamine-rich sequences of Hpnl would therefore appear 
to be warranted.  
 Although Hpn was shown to bind Bi(III) both in vitro and in vivo, there appears no reports on 
whether Hpnl interacts with Bi(III). We showed here that similar to the FRET-based study on Hpn 
[21], titration of up to six molar equivalents of Bi(III) to CYHpnl did not show significant FRET 
signals until high Bi(III) concentration, indicative of a weaker binding of Hpnl towards Bi(III) than 
Hpn as reflected from their binding affinities. This may be attributed to the fact that Hpnl protein 
lacks cysteine pairs which are usually favoured by the metal [40]. Unexpectedly, negative changes 
in FRET were detected when increasing amount of Bi(III) ions were incubated with the CYHpnl_1-
48-overexpressed cells. Similar negative changes in FRET have been reported previously 
[25,41,42], attributing to an increase in the distance between eCFP-eYFP FRET donor-acceptor 
pair upon protein-substrate interaction. The negative FRET signals observed in CYHpnl_1-48-
overexpressed cells may imply the interaction of CYHpnl_1-48 with Bi(III) ions. As confirmed by a 
home-made GE-ICP-MS, the distinct Bi(III) peak at approximately 75 kDa observed exclusively in 
209
Bi profile of cell lysate of CYHpnl_1-48-overexpressed cells (as well as CYHpnl-overexpressed 
cells, Fig. S7B-C) whereas was absence in CYFP-overexpressed E. coli cells (i.e. without 
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CYHpnl_1-48 and CYHpnl overexpression) under identical conditions, validating the intracellular 
binding of Bi(III) to both CYHpnl_1-48 and CYHpnl (Fig. S7A-C). Discrepancy in FRET responses 
between Bi(III) and other metal ions in in vivo suggested different conformational changes (or 
existence of distinctive binding sites) upon Bi(III) binding to CYHpnl. However, caution shall be 
taken that metal homeostasis in H. pylori may be different from that of the model bacterium E. coli. 
Nevertheless, FRET analyses on metal interaction with Hpnl in native organism H. pylori may be 
beneficial for future investigation. 
 This study provides comprehensive investigation of metal-binding properties of Hpnl in vitro 
and in cells although the FRET results might not represent all metal-CYHpnl interaction. Neither 
Co(II) nor Cu(II) binding to CYHpnl nor intracellular Bi(III)-binding to CYHpnl produced 
noticeable FRET signals (Table S2, Fig. S7A and S7C), which might be attributed to the limited 
conformational changes of the protein induced by the metals as shown in CD spectra (Fig. S5). 
Besides, the difference in oligomeric state between native Hpnl (as a 22-mer as reported in [11]) 
and CYHpnl (as a monomer as shown in Fig. S2 in this report) might lead to deviation in metal-
binding properties between native Hpnl and the fluorescent sensor protein CYHpnl. Examinations 
by other techniques, such as GE-ICP-MS, were thus used to compare with FRET results. 
Nevertheless, FRET analyses signify an indirect method to scrutinize protein-substrate interactions, 
confining to the conformational changes induced during interaction.  
5. Conclusion 
CYHpnl and CYHpnl_1-48 were constructed to investigate the interaction of Hpnl and Hpnl_1-48 
with metal ions. Binding to Ni(II) and Zn(II) resulted in the largest changes in FRET ratio and the 
dissociation constants were determined to be 4.6 and 3.4 M respectively. Ni(II) and Zn(II) also 
interact with CYHpnl and CYHpnl_1-48 in overexpressed bacterial cells. Our comparative FRET 
study for both CYHpnl and CYHpnl_1-48 indicated that the glutamine-rich C-terminus did not 
participate in direct coordination with metal ions although it might affect the metal-binding 
properties of Hpnl. The selectivity of CYHpnl towards Ni(II) both in vitro and in vivo elucidated the 
important role of Hpnl for sequestering nickel in H. pylori. Very weak but specific interaction of 
CYHpnl with Bi(III) was found. Negative FRET changes were observed after incubation with 
Bi(III) in cellular condition and binding of Bi(III) to CYHpnl in cells was confirmed by GE-ICP-
MS, indicative of different binding mode of Bi(III) compared with other metal ions. Finally, the 
FRET approach enables metal-protein interactions to be monitored directly in cells, offering a 
useful method for metalloproteomics [16,43].  
Abbreviations 
FRET Fluorescence Resonance Energy Transfer 
Hpnl Hpn-like 
CFP/YFP Cyan fluorescent protein / Yellow fluorescent protein 
CYHpnl Sensor protein with full-length hpnl gene inserted between ecfp and eyfp gene 
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CYHpnl_1-48 Sensor protein with C-terminal glutamine-rich region truncated hpnl gene 
 inserted between ecfp and eyfp gene 
CYFP Sensor protein with only eCFP and eYFP FRET donor-acceptor pair 
IPTG -D-1-isopropyl thiogalactopyranoside 
TCEP Tris(2-carboxyethyl)phosphine hydrochloride 
PMSF Phenylmethylsulfonyl fluoride 
MES 2-(N-morpholino)ethanesulfonic acid 
GE-ICP-MS Column-type gel electrophoresis coupled with inductively coupled plasma mass 
  spectrometry   
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